SAM Labs: Evangelizing the Problem
Summary:
Let’s start with the problem I had... SAM Labs launched into the US education market in 2018, after closing a series A round in 2017. SAM Labs then raised a second series A in 2019, on the back of new market growth and potential. The new funding did not lead to faster growth:
-
2019 annual revenue was down 20-25% YoY.
-
2020 Annual revenue was down 30-40% YoY.
This stood in contrast to the global edtech market, growing at roughly 20% YoY. The product lacked differentiation and organic appeal.
-
Qualitatively and quantitatively, they provided similar benefits to the financial buyer.
-
100% of our customers had purchased at least 2 of 7 major alternatives prior to SAM Labs.
-
Our ICP either had broken alternatives or hadn't implemented the alternatives yet.
Unable to win with brand, distribution, evidence, product differentiation, cash, etc. - I chose to evangelize the problem and create a unique POV. We began by championing of the problem our customers face, fabricating differentiation, trust, and domain expertise.
Step 1: The Why
For customer to purchase from a company, particularly in a B2B public sector setting, they must first trust the company. People are far more likely to trust, engage and empathize with another person than an organizational entity. The first thing I did was to encapsulate 'our why'. Why does SAM Labs exist?
This is the story. Well at least the prelude and first chapter. Us humans love stories and the best companies have a compelling origin story that appeals to their ICP. This was ours at SAM Labs.
Step 2: The Problem
If folks understand why SAM Labs exists, the next step is getting agreement SAM Labs should exist. What is the problem? Is it worth trying to fix? In other words, this is the information war every new company should fight.